Cytosorbents Corporation Common Stock (CTSO)

About CTSO

Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform in the United States, Germany, and internationally. Its flagship product, CytoSorb, is an extracorporeal blood purification cartridge to reduce cytokine storms in common critical illnesses, bilirubin in liver failure, myoglobin in trauma and critical illnesses, and in…

Sector

Health Care

Industry

Medical/Dental Instruments

Employees

129

Website

cytosorbents.com/

Fundamentals

1-day range

$0.32$0.3749

Market cap

$25.05M

P/E (trailing)

—

P/E (forward)

Infinity

EPS (trailing)

$-0.29

Dividend yield

—

Beta

1.31

Avg. volume

156.0K

Forecasts

2 analyst ratings

Cytosorbents Corporation Common Stock Competitors

Chosen by industry and closest market cap.

• CTSO

  Cytosorbents Corporation Common Stock

  $0.336

  ▼ 3.34%
  Market cap $25.05MP/E —
  $0.3$1.04
• BEAT

  Heartbeam Inc. Common Stock

  $0.4693

  ▼ 3.44%
  Market cap $28.33MP/E —
  $0.471$4
• PLRZ

  Polyrizon Ltd. Ordinary Shares

  $12.7

  ▼ 0.78%
  Market cap $21.51MP/E —
  $2.88$18.2
• RVP

  Retractable Technologies Inc. Common Stock

  $0.73

  ▲ 2.82%
  Market cap $20.27MP/E —
  $0.6017$1.14
• ARAY

  Accuray Incorporated Common Stock

  $0.2772

  ▲ 6.62%
  Market cap $33.63MP/E —
  $0.22$2.1
• OSRH

  OSR Health Inc. Common Stock

  $0.26

  ▲ 52.94%
  Market cap $15.32MP/E 10.53
  $0.075$0.9078
• NMTC

  NeuroOne Medical Technologies Corporation Common Stock

  $1.8

  ▼ 9.09%
  Market cap $13.36MP/E —
  $1.42$6.96

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• 12 Health Care Stocks Moving In Thursday's After-Market Session
  Benzinga · 8/20/2026
• 12 Health Care Stocks Moving In Tuesday's After-Market Session
  Benzinga · 8/11/2026
• Cytosorbents Corporation 2026 Q2 - Results - Earnings Call Presentation
  SeekingAlpha · 8/9/2026
• Cytosorbents Corporation (CTSO) Q2 2026 Earnings Call Transcript
  SeekingAlpha · 8/7/2026
• CytoSorbents Q2 Adj. EPS $(0.07) Misses $(0.04) Estimate, Sales $9.633M Beat $9.346M Estimate
  benzinga · 8/6/2026

• Peter J. Mariani · June 15, 2026 · Buy

  100.0K @ $0.44
• Phillip P. Chan · June 15, 2026 · Buy

  10.3K @ $0.43
• Phillip P. Chan · June 12, 2026 · Buy

  251.1K @ $0.4

Institutional Ownership

March 31, 2026

Total shares held

16.14M

Total value held

$9.13M

Institutional holders

47